Glen Santangelo
Stock Analyst at Jefferies
(2.31)
# 2,481
Out of 4,784 analysts
80
Total ratings
44%
Success rate
-1.14%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIP ANI Pharmaceuticals | Initiates: Buy | $80 | $67.61 | +18.33% | 1 | Mar 14, 2025 | |
| VTRS Viatris | Maintains: Buy | $15 → $13 | $8.68 | +49.77% | 4 | Mar 7, 2025 | |
| WAY Waystar Holding | Initiates: Buy | $51 | $37.83 | +34.81% | 1 | Feb 11, 2025 | |
| XERS Xeris Biopharma Holdings | Reiterates: Buy | $4 → $6 | $5.58 | +7.53% | 2 | Jan 29, 2025 | |
| NVST Envista Holdings | Maintains: Hold | $20 → $22 | $16.97 | +29.64% | 1 | Jan 23, 2025 | |
| XRAY DENTSPLY SIRONA | Downgrades: Hold | $30 → $20 | $14.93 | +33.96% | 2 | Jan 23, 2025 | |
| PCRX Pacira BioSciences | Maintains: Buy | $15 → $18 | $24.91 | -27.74% | 5 | Sep 24, 2024 | |
| PGNY Progyny | Maintains: Buy | $31 → $24 | $21.90 | +9.59% | 4 | Sep 19, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $8 → $10 | $8.09 | +23.61% | 6 | Sep 17, 2024 | |
| HIMS Hims & Hers Health | Maintains: Hold | $14 → $23 | $29.14 | -21.07% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $23 | $15.08 | +52.52% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $41 → $44 | $29.71 | +48.10% | 3 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $10.41 | +63.30% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $230 | $163.11 | +41.01% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.43 | +2,209.47% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $70 | $28.43 | +146.22% | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $14 | $6.99 | +100.29% | 2 | Feb 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $5.5 | $0.55 | +900.00% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $6.60 | +142.42% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $14 | $2.78 | +404.50% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $75 | $9.15 | +719.67% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $46 | $58.51 | -21.38% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $80 | $86.96 | -8.00% | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $4.55 | +515.38% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $26.00 | +169.23% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $7.82 | +1,434.53% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $2 | $2.63 | -23.95% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $4.50 | +944.44% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $2.94 | +1,124.49% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $67.14 | - | 3 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $173 → $169 | $668.06 | -74.70% | 5 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $31.21 | - | 2 | Jan 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $136.44 | - | 4 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $79 → $82 | $68.62 | +19.50% | 2 | Apr 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $159.21 | +57.03% | 1 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $78 | $11.19 | +597.05% | 1 | Dec 4, 2017 |
ANI Pharmaceuticals
Mar 14, 2025
Initiates: Buy
Price Target: $80
Current: $67.61
Upside: +18.33%
Viatris
Mar 7, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $8.68
Upside: +49.77%
Waystar Holding
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $37.83
Upside: +34.81%
Xeris Biopharma Holdings
Jan 29, 2025
Reiterates: Buy
Price Target: $4 → $6
Current: $5.58
Upside: +7.53%
Envista Holdings
Jan 23, 2025
Maintains: Hold
Price Target: $20 → $22
Current: $16.97
Upside: +29.64%
DENTSPLY SIRONA
Jan 23, 2025
Downgrades: Hold
Price Target: $30 → $20
Current: $14.93
Upside: +33.96%
Pacira BioSciences
Sep 24, 2024
Maintains: Buy
Price Target: $15 → $18
Current: $24.91
Upside: -27.74%
Progyny
Sep 19, 2024
Maintains: Buy
Price Target: $31 → $24
Current: $21.90
Upside: +9.59%
Teladoc Health
Sep 17, 2024
Maintains: Hold
Price Target: $8 → $10
Current: $8.09
Upside: +23.61%
Hims & Hers Health
Jun 27, 2024
Maintains: Hold
Price Target: $14 → $23
Current: $29.14
Upside: -21.07%
Jun 27, 2024
Maintains: Buy
Price Target: $19 → $23
Current: $15.08
Upside: +52.52%
Jun 7, 2024
Upgrades: Buy
Price Target: $41 → $44
Current: $29.71
Upside: +48.10%
Dec 19, 2023
Initiates: Buy
Price Target: $17
Current: $10.41
Upside: +63.30%
Dec 19, 2023
Assumes: Buy
Price Target: $230
Current: $163.11
Upside: +41.01%
Dec 15, 2023
Reiterates: Buy
Price Target: $10
Current: $0.43
Upside: +2,209.47%
Jul 25, 2023
Reinstates: Buy
Price Target: $70
Current: $28.43
Upside: +146.22%
Feb 9, 2023
Downgrades: Hold
Price Target: $14
Current: $6.99
Upside: +100.29%
Oct 21, 2022
Initiates: Hold
Price Target: $5.5
Current: $0.55
Upside: +900.00%
Oct 21, 2022
Initiates: Buy
Price Target: $16
Current: $6.60
Upside: +142.42%
Oct 21, 2022
Assumes: Buy
Price Target: $14
Current: $2.78
Upside: +404.50%
Oct 21, 2022
Assumes: Buy
Price Target: $75
Current: $9.15
Upside: +719.67%
May 18, 2022
Maintains: Buy
Price Target: $78 → $46
Current: $58.51
Upside: -21.38%
Mar 28, 2022
Maintains: Buy
Price Target: $62 → $80
Current: $86.96
Upside: -8.00%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $4.55
Upside: +515.38%
Dec 2, 2021
Initiates: Buy
Price Target: $70
Current: $26.00
Upside: +169.23%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $7.82
Upside: +1,434.53%
Dec 2, 2021
Initiates: Hold
Price Target: $2
Current: $2.63
Upside: -23.95%
Dec 2, 2021
Initiates: Buy
Price Target: $47
Current: $4.50
Upside: +944.44%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $2.94
Upside: +1,124.49%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $67.14
Upside: -
May 21, 2020
Maintains: Hold
Price Target: $173 → $169
Current: $668.06
Upside: -74.70%
Jan 7, 2020
Upgrades: Buy
Price Target: n/a
Current: $31.21
Upside: -
Dec 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $136.44
Upside: -
Apr 24, 2018
Maintains: Buy
Price Target: $79 → $82
Current: $68.62
Upside: +19.50%
Dec 8, 2017
Initiates: Hold
Price Target: $250
Current: $159.21
Upside: +57.03%
Dec 4, 2017
Initiates: Hold
Price Target: $78
Current: $11.19
Upside: +597.05%